background-splash

Tag: Pharvaris

A relative newcomer to the biotech scene, Pharvaris was founded by the team that successfully exited to BioMarin in 2015. With a promising pipeline, including treatments for rare diseases, Pharvaris is quickly gaining attention from investors and the medical community.

Never Miss a New Episode 💌

Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.

Watch & Subscribe